Glenmark Pharmaceuticals Ltd

Glenmark Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Glenmark Pharmaceuticals Ltd

₹ 1,922 -2.35%
08 Dec - close price
glenmarkpharma.com BSE: 532296 NSE: GLENMARK
About

Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries.[1]

Key Points

Leadership[1]

<h1>14th largest and fastest growing in the Indian market</h1> <h1>15th largest generic company by prescriptions filled in the USA</h1> <h1>5th largest Indian generic co. in Europe.</h1>
Website BSE NSE
  • Market Cap ₹ 54,236 Cr.
  • Current Price ₹ 1,922
  • High / Low ₹ 2,286 / 1,275
  • Stock P/E 36.9
  • Book Value ₹ 848
  • Dividend Yield 0.13 %
  • ROCE 9.72 %
  • ROE 7.35 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of 6.57% over past five years.
  • Company has a low return on equity of 7.72% over last 3 years.
  • Dividend payout has been low at 3.86% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare Nifty 500 BSE MidCap Nifty Pharma

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
2,208 2,161 1,939 2,144 2,233 1,365 2,148 2,330 2,636 2,251 2,010 2,395 1,539
1,826 1,723 1,721 1,659 1,790 1,549 1,651 1,698 1,857 1,757 1,669 1,667 1,717
Operating Profit 382 439 218 485 443 -184 497 631 779 494 341 728 -178
OPM % 17% 20% 11% 23% 20% -14% 23% 27% 30% 22% 17% 30% -12%
317 252 -425 18 54 234 5,933 56 83 129 -91 -254 -646
Interest 52 56 59 62 58 74 83 15 12 8 13 15 23
Depreciation 46 46 47 49 50 51 52 53 55 55 56 58 59
Profit before tax 601 589 -313 392 389 -76 6,295 618 795 559 181 401 -906
Tax % 30% 27% -56% 31% 22% -73% 27% 27% 25% 26% 18% 18% -18%
423 430 -137 272 302 -20 4,614 454 595 414 148 330 -739
EPS in Rs 15.00 15.26 -4.87 9.63 10.72 -0.72 163.50 16.08 21.09 14.66 5.24 11.70 -26.19
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
2,301 5,086 6,115 7,989 5,520 6,305 6,713 7,568 8,142 8,221 7,891 9,226 8,194
1,805 3,618 4,349 5,089 4,417 4,977 5,407 5,676 6,453 6,748 6,649 6,982 6,810
Operating Profit 496 1,467 1,766 2,900 1,103 1,328 1,305 1,892 1,689 1,473 1,242 2,244 1,385
OPM % 22% 29% 29% 36% 20% 21% 19% 25% 21% 18% 16% 24% 17%
67 -86 116 -89 326 954 624 469 1,044 490 6,238 177 -861
Interest 31 30 36 153 191 224 256 266 236 207 277 49 60
Depreciation 30 119 100 105 96 106 139 151 160 184 202 219 227
Profit before tax 502 1,232 1,747 2,553 1,143 1,952 1,535 1,944 2,337 1,572 7,001 2,154 235
Tax % 14% 18% 15% 16% 11% 17% 12% 15% 15% 23% 26% 25%
434 1,008 1,484 2,141 1,014 1,622 1,355 1,649 1,998 1,209 5,167 1,610 153
EPS in Rs 15.99 37.14 52.60 75.86 35.95 57.49 48.01 58.46 70.80 42.84 183.12 57.07 5.41
Dividend Payout % 12% 5% 4% 3% 6% 3% 5% 4% 4% 6% 1% 4%
Compounded Sales Growth
10 Years: 6%
5 Years: 7%
3 Years: 4%
TTM: -3%
Compounded Profit Growth
10 Years: 4%
5 Years: 5%
3 Years: 2%
TTM: -22%
Stock Price CAGR
10 Years: 8%
5 Years: 29%
3 Years: 64%
1 Year: 27%
Return on Equity
10 Years: 11%
5 Years: 9%
3 Years: 8%
Last Year: 7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 27 27 28 28 28 28 28 28 28 28 28 28 28
Reserves 2,879 4,925 7,338 9,408 10,363 11,914 13,198 14,781 16,710 17,849 22,942 24,476 23,911
353 410 787 2,777 2,981 3,134 3,574 3,704 3,738 3,221 707 830 476
970 2,289 1,960 1,787 1,892 2,066 2,152 2,104 2,438 3,487 3,736 2,700 3,969
Total Liabilities 4,230 7,651 10,113 14,001 15,265 17,143 18,952 20,618 22,914 24,586 27,414 28,033 28,384
449 1,231 1,438 1,596 1,699 1,413 1,612 1,722 1,752 1,746 1,756 1,979 2,013
CWIP 83 294 276 271 420 286 200 131 109 172 198 155 168
Investments 1,409 1,660 1,858 1,867 3,213 3,269 4,714 6,990 8,559 10,334 12,965 15,195 15,202
2,289 4,466 6,541 10,267 9,933 12,174 12,426 11,774 12,494 12,334 12,496 10,705 11,001
Total Assets 4,230 7,651 10,113 14,001 15,265 17,143 18,952 20,618 22,914 24,586 27,414 28,033 28,384

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
114 145 355 878 1,124 2,490 1,579 1,243 1,216 1,474 -495 589
211 -176 -1,545 -2,580 -1,137 -2,256 -1,607 -1,235 -897 -432 3,197 -490
-385 -32 1,223 1,879 -62 -155 -139 -81 -305 -978 -2,666 -95
Net Cash Flow -60 -64 32 177 -75 79 -168 -73 14 64 35 3

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 180 175 182 177 253 121 100 120 120 111 115 101
Inventory Days 126 161 182 172 195 141 115 94 102 117 130 156
Days Payable 337 343 306 221 273 258 217 201 208 225 307 242
Cash Conversion Cycle -31 -6 59 129 175 4 -3 14 14 3 -62 15
Working Capital Days 42 79 108 170 232 151 106 115 42 29 12 55
ROCE % 17% 33% 26% 29% 10% 13% 11% 12% 11% 11% 10% 10%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.64% 46.64%
23.19% 22.47% 25.51% 24.79% 23.71% 21.38% 20.98% 23.05% 23.51% 23.15% 20.62% 20.73%
10.69% 10.40% 9.10% 10.31% 10.92% 13.36% 13.93% 13.21% 13.85% 14.60% 17.64% 18.61%
0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
19.45% 20.46% 18.70% 18.21% 18.70% 18.58% 18.42% 17.06% 15.96% 15.56% 15.05% 13.97%
No. of Shareholders 3,00,1062,85,4612,36,9082,32,6852,09,9311,99,4511,92,6301,93,9491,95,0591,92,7241,90,2101,98,789

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls